The Mesothelioma Applied Research Foundation (Meso Foundation) is one of the leading advocates for research, education and funding for mesothelioma. As a non-profit organization, the foundation continues its efforts through the support of fellow mesothelioma advocates, including patients, doctors, lawyers and drug companies. The foundation has assembled its resources in an attempt to support patients while rigorously working towards a cure.
Driven by the passionate belief that a cure for malignant mesothelioma can be found, the Meso Foundation is working to capitalize upon the medical advancements that have been made in recent years. The foundation has launched several federal funding campaigns in Washington, D.C., generating attention at a national level. Additionally, the foundation focuses on supporting specific issues affecting the mesothelioma community.
While their advocacy branches continue to raise awareness and generate community involvement, their research department has investigated numerous ongoing trials and awarded funding to the most promising projects. In 2009, the foundation received 56 grant proposals and awarded a total of $800,000 to eight of the applicants.
Since its founding in 2000, the organization has awarded a total of 62 Meso Foundation Research Grants to various facilities around the world. Notable recipients include the Memorial Sloan-Kettering Cancer Center and Dr. Mitchell Ho of the National Cancer Institute.
As part of their attempt to spread knowledge about the rare cancer, the Meso Foundation is hosting an International Symposium on Malignant Mesothelioma in Washington D.C. running June 23-25, 2011. Held at the Omni Shoreham Hotel, the three-day conference is open to patients, loved ones, caregivers, medical professionals and other mesothelioma advocates. Functioning as both a peer networking opportunity and a source of information about the medical community’s current approach to the cancer, this symposium strives to empower attendees through distribution of knowledge.
Touching on topics such as intracavity chemotherapy, gene therapy and immunotherapy, the conference combines science and support for all involved. Registration for the event begins on March 15, 2011. Those who are unable to attend the seminar have access to other resources through the foundation’s online archives.